LEVETIRACETAM

APNAR PHARMA LP🇺🇸 United States

FDA Page

Effective Date: Jan 3, 2022
Approval ID: d46add79-d824-19ec-e053-2995a90aeced
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION, USP safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION, USP. LEVETIRACETAM oral solution, USP, for oral use Initial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.